Shield · 2 months ago
Strategic Account Sales
Shield is a global startup focused on compliance solutions for financial services, and they are seeking a Senior Account Executive to join their NYC team. This role involves developing new business, understanding client needs, and leading the sales process to drive company growth.
Artificial Intelligence (AI)ComplianceData VisualizationMachine LearningNatural Language ProcessingSaaS
Responsibilities
New business development across financial services to identify clients unique needs and challenges
Generate pipeline via targeted outbound (calls, emails, online outreach) and qualify inbound interest
Run a structured consultative process, and articulate a compelling value proposition
Understand client needs and build an effective strategic business plan that meets requirements
Navigate and lead the buying journey through progressive stages end to end
Be an ambassador for Shield at precept meeting and industry events
Orchestrate cross-functional teams both internally and externally to win complex deals
Maintain accurate CRM hygiene, forecasts, and next steps
Qualification
Required
5+ years of proven success in a quota-carrying B2B enterprise sales role focuses on new logo acquisition
Track record selling complex, multi-stakeholder solutions to financial institutions or large enterprises
Ability to translate technical capabilities into business outcomes for senior decision-makers
Entrepreneurial spirit with a sense of humor and humility
Enthusiasm for learning new technologies, storytelling, and deal management
Excellent written, verbal, and interpersonal communication; clear, candid with passion for persuasion
Preferred
Bonus if you have sound knowledge and experience within archiving/surveillance, capital markets, or regulation tech
Benefits
Company-paid benefits package
Competitive compensation (base + commission)
Flexible working model
Company
Shield
Shield is a workplace intelligence platform that automates the complete communications compliance lifecycle.
Funding
Current Stage
Growth StageTotal Funding
$35MKey Investors
Macquarie Capital
2022-12-01Series B· $20M
2022-01-13Series A· $15M
Recent News
2025-11-19
Sydney Morning Herald - Business
2025-11-14
Company data provided by crunchbase